Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Esophagus
Published in: Esophagus 3/2019

Open Access 01-07-2019 | Esophageal Cancer | Special Article

Comprehensive registry of esophageal cancer in Japan, 2012

Authors: Yuji Tachimori, Soji Ozawa, Hodaka Numasaki, Ryu Ishihara, Hisahiro Matsubara, Kei Muro, Tsuneo Oyama, Yasushi Toh, Harushi Udagawa, Takashi Uno, The Registration Committee for Esophageal Cancer of the Japan Esophageal Society

Published in: Esophagus | Issue 3/2019

Login to get access

Excerpt

We deeply appreciate the great contributions of many physicians in the registry of esophageal cancer cases. The Comprehensive Registry of Esophageal Cancer in Japan, 2012, was published here, despite some delay. The registry complies with the Act for the Protection of Personal Information. The encryption with a HASH function is used for anonymity in an unlinkable fashion. …
Literature
1.
Japan Esophageal Society. Japanese classification of esophageal cancer, 10th edition: part I. Esophagus. 2009;6:1–25.CrossRef
2.
Sobin LH, Gospodarowicz MK, Wittekind C. UICC International Union Against Cancer. TNM classification of malignant tumors. 7th ed. New York: Wiley-Blackwell; 2009.
Metadata
Title
Comprehensive registry of esophageal cancer in Japan, 2012
Authors
Yuji Tachimori
Soji Ozawa
Hodaka Numasaki
Ryu Ishihara
Hisahiro Matsubara
Kei Muro
Tsuneo Oyama
Yasushi Toh
Harushi Udagawa
Takashi Uno
The Registration Committee for Esophageal Cancer of the Japan Esophageal Society
Publication date
01-07-2019
Publisher
Springer Singapore
Published in
Esophagus / Issue 3/2019
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-019-00674-z

Other articles of this Issue 3/2019

Esophagus 3/2019 Go to the issue

Original Article

Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma

Original Article

White coat status is a predictive marker for post-esophageal endoscopic submucosal dissection stricture: a retrospective study

Original Article

The usefulness of three-dimensional video-assisted thoracoscopic esophagectomy in esophageal cancer patients

Original Article

Obesity and hiatal hernia may be non-allergic risk factors for esophageal eosinophilia in Japanese adults

Original Article

Is complete right cervical paraesophageal lymph node dissection possible in the prone position during thoracoscopic esophagectomy?

Original Article

Palliative interventions for patients with incurable locally advanced or metastatic thoracic esophageal carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits